Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Confidence. Delivered.

LBgard® Blood Tubes will be right back.
We are expanding the applications for use.

Sign up here to stay in touch.

Contact Us


The current version of the LBgard Blood Tubes are not available for sale while we are actively expanding the applications for use. We anticipate availability in 2022.

In the meantime, we would be happy to take your contact information to stay in touch. Additionally, there may be opportunities to participate in studies and/or evaluations of the LBgard Blood Tubes. If you are interested in learning more, please fill out the information below, and we will reach out as opportunities become available.


LBgard Blood Tubes are manufactured by Biomatrica, an Exact Sciences Company